Exhibitors Search

RECEPTECH, Inc.

Booth no. A60
Exhibition PARTNERING
Country Korea, South
Address 82 Baegot 2-ro, Siheung-si, Gyeonggi-do, Republic of Korea
Tel (Rep.) 010-9425-4723
E-mail  
Website http://receptech.com

Company Introduction

RecepTech Inc.'s core technology is to develop products that can be applied to various fields through the technology to mass-produce and purify various receptors in E. coli system and the technology to manufacture them into nanodisc.

1. Business Goal - Company is the 'First Mover" in the commercialization of receptor technologies in Health Care (innovative disease diagnosis, new drug screening), Safety Care (detection of virus, hazard/malordorant substance in air, water, and food), and Standardization (in information technologies of sensing, storage, transmission, and reproduction of olfactory/taste receptor signals).

2. Core Value - Company keeps sharpening and securing core technologies in order to provide healthy and happy life with the work-ethics of cooperation, commitment, and perseverance.

Promotional video

Exhibit Item

A Targeted Anticancer Antibody Screening Platform Based on Cancer Cell-specific GPCR (G-protein-coupled receptor) Nanodisc Antigen

Exhibit Item Images

  • Product Name : A Targeted Anticancer Antibody Screening Platform Based on Cancer Cell-specific GPCR (G-protein-coupled receptor) Nanodisc Antigen
    Products using this technology are cancer cell-targeting antibody and small molecule screening system using cancer cell-specific (G-protein-coupled receptor) nanodisc antigen. which can accurately and quickly discover various cancer cell-targeting anticancer antibody and small molecule candidates.
  • Product Name :  
     
  • Product Name :  
     
  • Product Name :  
     
  • Product Name :  
     

Exhibit Description

Products using this technology are cancer cell-targeting antibody and small molecule screening system using cancer cell-specific (G-protein-coupled receptor) nanodisc antigen. which can accurately and quickly discover various cancer cell-targeting anticancer antibody and small molecule candidates.

Co-Exhibitor or
Partner’s Information

Company Name Country
  
Website http://
Website http://
Website http://
Website http://
Website http://